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Clonal expansion of mtDNA 
deletions: different disease models 
assessed by digital droplet PCR in 
single muscle cells
Selena Trifunov1,2, Angela Pyle2, Maria Lucia Valentino1,3, Rocco Liguori1,3, Patrick Yu-Wai-Man4,5, 
Florence Burté2, Jennifer Duff 2, Stephanie Kleinle  6, Isabel Diebold6, Michela Rugolo7, 
Rita Horvath2 & Valerio Carelli1,3
Deletions in mitochondrial DNA (mtDNA) are an important cause of human disease and their 
accumulation has been implicated in the ageing process. As mtDNA is a high copy number genome, the 
coexistence of deleted and wild-type mtDNA molecules within a single cell defines heteroplasmy. When 
deleted mtDNA molecules, driven by intracellular clonal expansion, reach a sufficiently high level, a 
biochemical defect emerges, contributing to the appearance and progression of clinical pathology. 
Consequently, it is relevant to determine the heteroplasmy levels within individual cells to understand 
the mechanism of clonal expansion. Heteroplasmy is reflected in a mosaic distribution of cytochrome 
c oxidase (COX)-deficient muscle fibers. We applied droplet digital PCR (ddPCR) to single muscle 
fibers collected by laser-capture microdissection (LCM) from muscle biopsies of patients with different 
paradigms of mitochondrial disease, characterized by the accumulation of single or multiple mtDNA 
deletions. By combining these two sensitive approaches, ddPCR and LCM, we document different 
models of clonal expansion in patients with single and multiple mtDNA deletions, implicating different 
mechanisms and time points for the development of COX deficiency in these molecularly distinct 
mitochondrial cytopathies.
Mitochondria are cytoplasmic organelles crucially involved in respiration and energy production of eukaryotic 
cells, unique for containing their own maternally inherited genome1. Human mitochondrial DNA (mtDNA) 
is a small, circular, intronless 16.6 kb long molecule, encoding 37 genes, precisely 13 proteins of the oxidative 
phosphorylation (OXPHOS) system, 22 transfer RNAs (tRNAs) and 2 ribosomal RNAs (rRNAs). Furthermore, 
mtDNA is a high copy number genome and mitochondrial mass varies amongst different cell and tissue types 
depending on the metabolic demands2.
The first mtDNA mutations associated with human diseases were deletions in patients with mitochondrial 
myopathies3 and a missense point mutation in patients with Leber’s hereditary optic neuropathy4. The mtDNA 
deletions remove various portions of the genome, resulting in shorter molecules, and they may occur either as 
single or multiple deletions5,6.
Single, large-scale deletions cause sporadic diseases, which may start in early childhood such as Pearson 
and Kearns-Sayre syndromes or, later in life, such as chronic progressive external ophthalmoplegia (CPEO)7. 
Single mtDNA deletions are considered sporadic, somatic mutational events occurring early during embryonic 
development in the majority of cases. However, the 4977bp “common deletion” was found to exist at very low 
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heteroplasmic loads in unfertilized oocytes8–10. Interestingly, a few cases of maternally inherited single mtDNA 
deletions have been reported and considered rare exceptions10–14.
Differently, multiple mtDNA deletions may accumulate somatically in post-mitotic tissues secondary to muta-
tions in nuclear genes inherited as Mendelian traits, directly involved in mtDNA replication, or in the nucleo-
tide pool balance or, more recently, in mitochondrial dynamics15. Thus, mtDNA deletions generated by different 
genetic defects may propagate within muscle fibers with different modes and timing.
Deleted mtDNA molecules coexist with wild-type mtDNA, resulting in a heterogeneous intracellular pool of 
mitochondrial genomes known as heteroplasmy2. Over time, some of the deleted mtDNA species can accumu-
late to high loads due to clonal expansion, which may occur both in germline and somatic cells. Thus, hetero-
plasmy may vary amongst cells and tissues, impinging on the phenotypic expression of mitochondrial disorders, 
and clonal expansion becomes the driving force, as deleted mtDNA molecules become the prevalent population 
within single cells16. The mechanisms beyond this process have not been fully determined due to technical limi-
tations. Crucially, the investigation of clonal expansion patterns requires a precise quantitative assay to determine 
the proportion of deleted and wild type mtDNA molecules at the single cell level. This assay should be performed 
at different locations of the same cell, according to histochemical demonstration of mitochondrial dysfunction, 
such as muscle fiber domains deficient for cytochrome c oxidase (COX). Recently, a sensitive and powerful tech-
nique, droplet digital PCR (ddPCR), has been developed for quantifying deleted mtDNA and it was demonstrated 
to be more precise compared with conventional real-time quantitative PCR (qPCR) techniques. A major benefit 
of ddPCR in heteroplasmy quantification is that it does not require external standards, thus limiting the error 
rates. Partitioning of samples, as in single molecule PCR, brings enhanced sensitivity and the final reaction is 
visualized using fluorescence rather than gel analysis17,18.
To better understand the chronology and mechanisms driving clonal expansion of deleted mtDNA mole-
cules, we used the ddPCR approach to analyze single muscle cells collected by laser-capture microdissection 
of both transversal and longitudinal sections. We compared three different molecular paradigms of disease, i.e. 
single large-scale mtDNA deletions and multiple DNA deletions caused by nuclear mutations in the OPA1 (Optic 
Atrophy 1) or POLG (Polymerase γ) genes.
Materials and Methods
Patients. We studied 7 patients presenting with three different pathologies associated with accumulation 
of mtDNA deletions in the skeletal muscle (Table 1). Patients 1 and 2 harbored a dominant mutation in the 
OPA1 gene and were clinically affected by a dominant optic atrophy (DOA) “plus” syndrome; patients 3 and 4 
carried recessive mutations in the POLG gene and were clinically affected by SANDO syndrome (Sensory Ataxic 
Neuropathy, Dysarthria, Ophthalmoparesis); finally, patients 5, 6 and 7 were sporadic cases carrying a single 
mtDNA deletion (two with the “common deletion” and one with a 5992bp deletion) and affected with CPEO. 
We aimed to represent three different categories of mitochondrial disorders: patients with OPA1 mutations may 
accumulate mtDNA multiple deletions because of defective mitochondrial dynamics, patients with POLG muta-
tions present with pathological mtDNA maintenance due to defective mtDNA replication, and patients with 
single mtDNA deletion are the paradigm of sporadic events of somatic deletion. We also studied 3 age-matched 
individuals with normal muscle histology and histochemistry as controls (Table 1). A brief description of the 
patients is provided in the Supplemental Material. Patients 1 and 2 were previously reported19,20. Additionally, 
we have investigated blood DNA samples from 16 patients with Pearson and Kearns Sayre syndromes or CPEO, 
for the presence of mtDNA deletions, and a brief description of these patients is reported in Table S1. For all 
cases informed consent and a muscle biopsy was obtained, and the local Ethics Committee “Comitato Etico 
Case and phenotype Genetic defect
Age at 
time of 
biopsy Sex
Nuclear gene mutation or 
mtDNA deletion breakpoints AA change
Heteroplasmy 
estimation of muscle 
biopsy DNA
P1
(DOA plus)
OPA1 heterozygous 
missense 66 M
OPA1
c.1462G>A p.G488R
56%
(Southern blot)
P2 
(DOA plus)
OPA1 heterozygous 
missense 42 M
OPA1
c.1316G>T p.G439V
37%
(Southern blot)
P3 
(SANDO)
POLG heterozygous 
missense and insertion 53 M
POLG1
c.934T>C
c.3629insA
p.W312R 
and 
p.Y1210X
76%
(Southern blot)
P4
(SANDO, Parkinsonism)
POLG homozygous 
missense 57 F
POLG1
c.1943C>G p.P648R
64%
(Southern blot)
P5 
(CPEO) mtDNA single deletion
a 49 M mtDNAnt.8469-nt.13447 NA NA
P6
(CPEO) mtDNA single deletion
a 18 F mtDNAnt.8469-nt.13447 NA
74%
(Southern blot)
P7
(CPEO) mtDNA single deletion 50 M
mtDNA
nt.9431-nt.15423 NA NA
C1 Control 1 37 F NA NA NA
C2 Control 2 20 F NA NA NA
C3 Control 3 41 F NA NA NA
Table 1. Characteristics of muscle biopsy samples used in this study. AA, amino acid; F, female; M, male; NA, 
not applicable. aCommon deletion.
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Interaziendale Bologna-Imola-Ferrara (CE-BIF) #13036” approved the study. All experiments and methods were 
performed in accordance with relevant guidelines and regulations. Each case has been molecularly defined by 
standard approaches such as Southern blot or quantitative real time PCR, and the heteroplasmic load of single/
multiple deletions is reported in Table 1.
Figure 1. Representative muscle biopsies: COX/SDH staining and ddPCR plots. (A) Longitudinal biopsy section. 
(B) Transverse biopsy section with COX negative cell labelled as 1. (C) RBF cell labelled as 2. (D) Intermediate 
cell labelled as 3 and COX positive cell labelled as 4. (E) Example of ddPCR 1D plot where each droplet from a 
sample is plotted on the graph of fluorescence intensity vs. droplet number. All positive droplets, blue for FAM or 
green for HEX, are scored as positive and each is assigned a value of 1. All negative droplets (grey), are scored as 
negative. (F) The histogram which plots amplitude vs. the frequency of the populations of droplets.
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Transversal and longitudinal muscle biopsy sectioning. Open quadriceps muscle biopsies were 
taken under local anesthesia from all patients as well as from controls. All muscle biopsies were frozen in liq-
uid nitrogen-cooled isopentane and stored at −80 °C until processed. Adjacent 10-µm sections were cut using 
a cryostat microtome and mounted on PEN membrane glass slides (Thermofisher). In this study, we used both 
transversal and longitudinal sections of the muscle biopsy (Fig. 1A,B). We were successful in obtaining longitu-
dinal sections from only three of the muscle biopsies (patients 1, 3 and 5), due to the known difficulties in cutting 
sections from frozen tissue through long segments of individual muscle fibers21.
Histochemical analysis and classification of individual muscle fibers. To highlight the muscle fiber 
segments deficient for OXPHOS, sequential Cytochrome c Oxidase (COX)/succinate dehydrogenase (SDH) his-
tochemistry was carried out on each section in the same incubation. COX is partially encoded by mtDNA (COXI, 
II and III subunits), thus COX activity becomes deficient if mtDNA deletion crosses a certain threshold of hetero-
plasmy. SDH, on the contrary, is completely encoded by nuclear DNA, thus its enzymatic activity persists even in 
the presence of high loads of mtDNA deletion, or when a strong compensatory mitochondrial biogenesis occurs 
in the so-called ragged-blue-fibers (RBF)22. In fact, the RBF fibers are characterized by a massive accumulation of 
abnormal mitochondria that is visually distinctive compared to the other COX negative cells, as evidenced by a 
deep blue SDH reaction equivalent to the ragged red fibers. COX activity was demonstrated histochemically in a 
medium containing 4 mM 3,3′- diaminobenzidine tetrahydrochloride (DAB) and 100 mM cytochrome c (Sigma) 
in 0.1 M phosphate buffer, pH 7.0 at 37 °C. SDH activity was assayed by using 1.5 mM nitrobluetetrazolium, 130 
mM sodium succinate, 0.2 mM phenazine methosulfate, and 1.0 mM sodium azide in 0.1 M phosphate, pH 7.0 at 
37 °C. COX activity was detected after 40-min incubation, allowing the detection of histochemically COX posi-
tive muscle tissue. The incubation time for the SDH reaction was 30 min, allowing the detection of SDH activity, 
which was prevalent or exclusive in COX negative/SDH positive fibers23.
According to the COX/SDH staining muscle fibers were classified as COX positive (brown), COX intermedi-
ate (grey), COX negative (blue), RBFs (intense blue) (representative images are reported in Fig. 1B–D, all sections 
are reported in Fig. S1).
Laser Capture Microdissection. The Leica laser capture microdissection (LCM) system (Leica Biosystems) 
was used, following manufacturer’s instructions to isolate 12-µm thick COX positive, COX intermediate, COX 
negative and RBF regions of single fibers, in both transversal and longitudinal sections. Prior to collection, each 
fiber was numbered and the total surface of the fiber was measured. This system uses UV laser and gravity col-
lection. Presence of the single fiber in the collection tubes was always verified. Before microdissection, the tissue 
sections were subjected to an ethanol and dehydration series for 10–15 min at each step.
Figure 2. Comparison between ddPCR and Southern blot results on muscle homogenate or blood DNA. 
Southern blot indicated mtDNA deletion levels of 76.0% and 74.0% in DNA extracted from muscle 
homogenates of patients 3 and 6, respectively. Mean values from ddPCR were 73.1% (SD = 2.3) and 53.0% 
(SD = 4), respectively. In patients 22 and 23, heteroplasmy rate of mtDNA deletions on Southern blot in 
blood derived DNA was 70.0% and 50.0%, while ddPCR estimated 63.7% (SD = 0.58) and 55.7% (SD = 3.2), 
respectively. Heteroplasmy rate of mtDNA deletions in muscle homogenate DNA from controls 1 and 2 
validated by ddPCR was 1.0% (SD = 0.8) and 0.9% (SD = 0.8), respectively. All ddPCR experiments were 
performed in triplicates. The SD values are presented as error bars.
ND1 Forward 5′-CCCTAAAACCCGCCACATCT-3′
ND1 Reverse 5′-GAGCGATGGTGAGAGCTAAGGT-3′
ND1 Probe 5′-FAM/CCATCACCCTCTACATCACCGCCC/BHQ1-3′
ND4 Forward 5′-CCATTCTCCTCCTATCCCTCAAC-3′
ND4 Reverse 5′-CACAATCTGATGTTTTGGTTAAACTATATTT-3′
ND4 Probe 5′-HEX/CCGACATCATTACCGGGTTTTCCTCTTG/BHQ2-3′
Table 2. Primers and probes used in ddPCR experiments. Primer numbers refer to the mtDNA Genbank 
reference sequence NC 012920.1.
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Lysis of single cells for DNA amplification. Laser dissected cells were lysed in 2.5 ul of lysis buffer con-
taining: 50 mM Tris-HCl pH 8.5, 200 ng/ml of Proteinase K (Invitrogen) and 1% Tween (Sigma). Cells were 
incubated for 16 hours at 55 °C and then 10 minutes at 95 °C for denaturation of Proteinase K. After the lysis, 
cells were digested for 1 hour at 37 °C with enzyme PvuII (Thermo Fisher Scientific) following the manufacturer’s 
instruction.
Digital droplet PCR of DNA extracted from single cells. After the lysis and digestion, mtDNA dele-
tion levels were analyzed and detected using the duplex MTND1/MTND4 method. Digital PCR analysis was per-
formed according to the published protocol established on DNA derived from muscle homogenates with certain 
modifications due to the different ddPCR platform used18. The limited amount of available DNA from single cells 
did not allow DNA quantification prior to analysis. Primer and probe sequences are shown in Table 2. (Primer 
numbers refer to the mtDNA Genbank reference sequence NC 012920.1).
The 20 ul reactions consisted of 1X digital PCR supermix for probes (Bio-Rad Laboratories), 375 nM of ND1 
probe, 900 nM of ND1 primers, 125 nM of ND4 probe, 450 nM ND4 primers and nuclease-free water. Reactions 
were transferred to 96-well plates (Eppendorf) and droplet generation was carried out in an Automated Droplet 
Generator with DG32 cartridges (Bio-Rad Laboratories). Automated Droplet Generator partitions samples into 
around 20,000 nanoliter-sized droplets. Droplets are automatically transferred to 96-well plates ready for further 
amplification. PCR reactions were performed on a C1000 Touch thermal cycler (Bio-Rad Laboratories) using 
standard cycling conditions as follows: 95 °C-10 minutes, 40 cycles of 94 °C-30 seconds, 40 cycles of 60 °C-1 minute 
and 98 °C- 10 minutes.
Following PCR amplification of the nucleic acid target, droplets were analyzed on a QX200 Droplet Digital 
PCR (ddPCR™). Each droplet was analyzed individually using a two-color detection system (set to detect FAM 
and HEX); PCR-positive and PCR-negative droplets are counted to provide absolute quantification of target DNA 
in digital form using QuantaSoft™Pro software (Bio-Rad). Results are collected and visually examined in 1D and 
2D plots as represented in Fig. 1E. The level of mtDNA wild type molecules is calculated by dividing the absolute 
number of MTND4 with MTND1 and the percentage of mtDNA deletion is 1-wt molecules24. The mtDNA copy 
number density was measured at the single fiber level and presents the total number of mtDNA molecules in a 
muscle fiber section, divided by the fiber’s cross-sectional area25 . Each sample was assessed in triplicate.
Single cell long range PCR. Long range PCR was carried out using PrimeSTAR GXL DNA polymerase 
(TaKaRa, Clontech) on available DNA samples extracted from individual muscle fibers. Briefly, single muscle 
fibers were laser dissected, lysed and digested as described earlier. Due to limited amounts of DNA, quantification 
prior to PCR was not possible. Primer pairs were: forward 6222–6240 and reverse 16133–16153. Reaction was 
prepared as follows: 1× buffer, 0.2 uMdNTP mix, 0.4 uM forward and reverse primers, 0.625 unit polymerase and 
3 ul DNA. Cycling conditions were: 94 °C-1 minute; 35 cycles of 94 °C-10 seconds, 60 °C-15 seconds and 68 °C-10 
minutes; 72 °C-10 minutes. Amplified PCR products were separated through 0.7% agarose gels. Smaller bands, 
suggesting the presence of mtDNA deletions were cut out of gels. DNA was extracted according to manufacturer’s 
protocol with QIAquick Gel Extraction Kit (Qiagen) and sequenced on an ABI3130xl using BigDye terminator 
v3.1.
Statistical analysis. For the purpose of group comparisons, ANOVA statistical analysis was performed 
using GraphPad™ v.5 statistical software (GraphPad Software). Group comparisons were considered to be sta-
tistically non-significant (ns) if the calculated P-value was greater than 0.05, significant (*) with P = 0.01 to 0.05, 
very significant (**) with P = 0.001 to 0.01 and extremely significant (***) when the P-value was less than 0.001.
Data availability statement. The datasets generated during and/or analysed during the current study are 
available from the corresponding author on reasonable request.
Results
Validation of ddPCR by comparison with Southern blot. To validate the ddPCR method, we used 
homogenate muscle DNA extracted from muscle biopsies of patients carrying single or multiple mtDNA dele-
tions that had previously been identified by Southern blot. A major advantage of ddPCR is its high sensitivity 
and consequently, the amount of DNA required is significantly lower compared with that needed for Southern 
blotting. We detected similar heteroplasmy loads with these two methods (Fig. 2). As a drawback, the size of the 
deletion is not assessed by ddPCR, and can only be estimated with good approximation by Southern blot. As we 
found that ddPCR is much more sensitive than Southern blot in detecting and quantifying mtDNA deletions, we 
also tested whether it detects single mtDNA deletions in blood cells from patients with the Pearson and Kearns 
Sayre syndromes or CPEO (n = 16). Single mtDNA deletions had previously been found in homogenate muscle 
DNA by long range PCR and/or Southern blot. Results of ddPCR and Southern blot with heteroplasmy estima-
tion as well as long-range PCR results for these samples are summarized in Table S1. We could only detect single 
mtDNA deletions in blood cells of two children with clinical presentation of Pearson syndrome (<1 year old) and 
Kearns-Sayre Syndrome (16 years old). In both children, the deletion was also detectable on LR-PCR. In blood 
DNA of adult patients with CPEO, ddPCR failed to detect the single mtDNA deletion.
COX/SDH activities define the pattern of OXPHOS impairment at the single fiber level. 
Histochemical staining of muscle biopsy sections is an established method of demonstrating OXPHOS impairment and 
four subpopulations of muscle cells can be distinguished: COX positive, COX intermediate, COX negative, and RBF 
(Fig. 1). Skeletal muscle is therefore the tissue of choice to investigate the clonal expansion of deleted mtDNA in single 
cell populations that exhibit different OXPHOS deficits. We investigated both single mtDNA deletions and multiple 
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mtDNA deletions secondary to POLG and OPA1 mutations. To fully explore the distribution of deleted mtDNA, we 
performed our quantitative assessment on both transverse and longitudinal biopsy sections. Overall, we investigated 
individual fibers collected by laser capture micro-dissection in 7 patients and 3 controls: COX positive (n = 265), COX 
negative (n = 70), intermediate (n = 98) and RBF (n = 52) (Fig. 1A–D and Fig. S1).
COX negative fibers were absent in the control muscle specimens. The lowest percentages of COX negative 
fibers were found in the biopsies from Patients 1 and 2, who both carried a heterozygous dominant OPA1 muta-
tion, with levels of 2.5% and 5%, respectively. The highest percentages of COX negative fibers were found in 
the muscle of Patient 5 (28.5%) who carried a single “common” deletion, and in Patient 3 (28.3%) who carried 
recessive POLG mutations. The percentages of COX negative fibers in Patient 3 also included the RBFs. The per-
centage of intermediate fibers was lowest in Patients 1 and 2, being 2% and 4.3%, respectively. The highest load 
of intermediate fibers was found in the biopsy from Patient 3 (20.7%) and Patient 6 (18.5%), who carried a single 
“common” deletion (Table 3).
Levels of mtDNA deletions in two patients with OPA1 mutations and DOA “plus”. We assessed 
the mtDNA deletion load by ddPCR in COX negative fibers (n = 17), intermediate fibers (n = 17) and COX posi-
tive fibers (n = 27) dissected by LCM from muscle biopsies of Patients 1 and 2 (Fig. 3). The mean value of deletion 
load in COX negative fibers was 78.5% (SD = 30.8). Deletion load was lower in intermediate fibers, with a mean 
value of 29.2% (SD = 39). In COX positive fibers from the OPA1 group, mtDNA deletions were hardly detected, 
with a mean deletion load of 0.3% (SD = 0.8). Deletions were absent in two of the COX negative fibers from 
Patient 1. This value was not different from that assessed in COX positive fibers from controls (n = 105), with a 
mean of 0.5% (SD = 1.3) (Fig. 3).
Levels of mtDNA deletions in two patients with autosomal recessive POLG mutations and 
SANDO. The mean mtDNA deletion load in COX negative fibers (n = 15) from Patients 3 and 4 was 81% 
(SD = 13.3). We also analyzed separately the subcategory of COX negative fibers defined as RBFs (n = 29). These 
fibers expressed the highest levels of mtDNA deletions, with a mean value of deleted molecules reaching 94.1% 
(SD = 4.1) (Fig. 3). Intermediate fibers (n = 35) harbored a mean deletion load of 65 % (SD = 27.07). COX posi-
tive fibers (n = 69) had a limited load of deleted molecules, reaching the mean value of 2.1% (SD = 4), not statis-
tically different from controls (Fig. 3).
Levels of the single mtDNA deletion in three patients with CPEO. The mean deletion load 
in COX negative fibers (n = 37) of Patients 5, 6 and 7 was 93.1 % (SD = 5.4) compared with a mean value of 
96.8% (SD = 1.4) for RBFs (n = 23). Deletion load in intermediate cells had a mean value of 80.5% (SD = 12.5). 
Remarkably, more than 50% (27 out of 55 COX positive fibers) harbored variable percentages of mtDNA deletion, 
reaching a mean value of 15.8% (SD = 25) (Fig. 3).
Different profiles of mtDNA deletion accumulation amongst the patient groups. The mtDNA 
deletion levels in COX negative fibers from single deletion patients were significantly higher (P < 0.05*), with a 
mean value of 93.08% compared with 78.5% and 81% in OPA1 and POLG patients, respectively. However, there 
were no significant differences of deletion levels in COX negative cells between OPA1 and POLG patients. RBFs 
were only observed in the POLG and single deletion groups, and significantly higher percentages were present in 
the single deletion group compared with the POLG group (*P < 0.05).
The intermediate fibers still retain a partial COX activity, approaching the threshold level to turning into COX 
negative. Our results showed that this threshold might be different at the single fiber level. In fact, the load of 
mtDNA deletions in single intermediate fibers varied in each patient group, from a mean value of 29.2% in the 
OPA1 patients, 65% in POLG patients and 80.5% in single deletion patients. Again, the patterns of mtDNA dele-
tion accumulation were significantly different (***p < 0.0001) when the three groups were compared.
As COX-positive fibers are considered to be fully functional with normal OXPHOS activity, these cells are 
assumed to generally have either no mtDNA deletions or very low amounts, below a certain threshold25,26. Our 
ddPCR results, obtained from a large number of COX-positive fibers (n = 265) collected from patients and controls, 
showed that COX-positive cells from single deletion patients had a significantly larger accumulation of mtDNA 
deletions when compared to both POLG and OPA1 patients, and with the control group (***P < 0.0001) (Fig. 3).
Case Genetic defect
%COX negative 
(including RBF’s)
%COX 
intermediate
P1 OPA1 2.53 2
P 2 OPA1 5 4.3
P 3 POLG 28.3 20.7
P 4 POLG 12.5 16
P 5 SINGLE DELETION 28.5 16.5
P 6 SINGLE DELETION 3.94 18.5
P 7 SINGLE DELETION 10.8 20
Table 3. Proportion of COX negative fibers, RBFs and intermediate fibers.
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Levels of mtDNA deletions in longitudinal muscle biopsy sections. All previous assessments 
of mtDNA deletion loads were performed in single fibers dissected by laser capturing from a cross-sectional 
profile of the fiber in transverse sections of the muscle biopsy. Thus, each evaluation refers to distinct cells. 
However, muscle fibers viewed in longitudinal section may display COX-positive domains intermixed with 
COX-intermediate/COX-negative domains21. Thus, within the same muscle fiber the mtDNA deleted molecules 
are accumulated by clonal expansion in specific domains. To explore this feature in our samples we applied LCM 
to longitudinal sections obtained from the muscle biopsies of patients 1, 3 and 5, representative of each patho-
logical group. COX-positive domains were analyzed and compared with COX-negative domains from the same 
fibers in each group.
This analysis confirmed that the single deletion group had the highest levels of mtDNA deletion in the COX 
negative domains of individual fibers (mean = 87.32%, SD = 4.06) as compared with the OPA1 (mean = 76.88%, 
SD = 8.43) and POLG (mean = 56.34%, SD = 34.82) groups. Similarly, the assessment in COX positive domains 
of the same individual fibers paralleled the previous results from muscle cross-sections, with the single deletion 
group having the highest load of mtDNA deleted molecules (mean=42.8%, SD = 11.7) compared with the OPA1 
(mean = 1.5%, SD = 2.3) and POLG (mean = 16.2%, SD = 18.7) groups (Fig. 4).
Qualitatively, more defined areas of COX negativity were visualized in POLG and OPA1 longitudinal sections 
of muscle biopsies. In comparison, longitudinal fibers from the single deletion case had a wider dispersion of 
COX negativity. In fact, it was challenging to select fibers from the single deletion case that contained well defined 
COX negative and COX positive zones, due to frequent areas of blue staining invading the entire length of the 
fiber in a stripe-like fashion. We also sampled those fibers that appeared entirely COX positive along their longi-
tudinal length (Fig. S2). In this latter case, we found a significant amount of mtDNA deletion in two fully COX 
positive longitudinal fibers (fiber 1: mean 30%; fiber 2: mean 60.4%), highlighting the hallmark of the single dele-
tion cases that had widespread amounts of mtDNA deletion affecting fibers with apparently functional OXPHOS.
To further confirm our ddPCR findings, we used long-range PCR to amplify DNA extracted from single lon-
gitudinal fibers. Long-range PCR is not a quantitative method as it preferentially amplifies the shorter, deleted 
mtDNA molecules, thus it is not used for accurate determination of the heteroplasmy of deletions. However, it 
was useful to confirm the presence of deleted mtDNA molecules in COX positive longitudinal fibers from single 
deletion patient by this approach (Fig. S3).
MtDNA copy number assessment reveals compensatory mtDNA proliferation in muscle fibers 
with impaired OXPHOS. We compared total mtDNA copy number per um2 between the different subcate-
gories of fibers in patients and controls. MtDNA copy number was variable in the control group, ranging from 0.4 
to 3.6 copies/um2 with a mean value of 1.7 (SD = 0.7). This variability is possibly due to differences in type 1 and 2 
fibers ratio, and to the variable level of physical activity27. Our results revealed that COX negative, RBFs and inter-
mediate fibers from the single deletion group had a significant increase in mtDNA density compared with healthy 
Figure 3. Level of mtDNA deletions obtained with ddPCR in single muscle fibers. (A) COX positive (brown 
dots), COX negative (light blue dots) and intermediate fibres (grey dots). The groups represent pooled data of 
fibres from different patients OPA1 (P1 and P2); POLG (P3 and P4); Single deletion (P5, P6 and P7); Control 
(C1, C2 and C3). All measurements were performed in triplicates. The mean values for each group of fibres are 
presented with black horizontal lines. (B) Level of mtDNA deletions obtained with ddPCR in RBF fibres. These 
fibers were present only in the POLG and single deletion groups.
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controls, similar to the RBFs from the POLG group. The deletion load was higher in fibers with high mtDNA copy 
numbers. COX positive fibers from all groups, as well as COX negative and intermediate from POLG and OPA1 
group, did show increased values compared to controls, failing to achieve statistical significance (Fig. 5).
Discussion
We have shown that ddPCR is a sensitive and reliable assay to quantify the level of single or multiple mtDNA 
deletions in individual muscle fibers. Three groups of patients with mitochondrial disease were assessed (single 
large-scale mtDNA deletion and multiple mtDNA deletions due to pathogenic OPA1 and POLG mutations) in 
single muscle fibers laser captured in transverse and longitudinal sections of muscle biopsies. Different domains 
of the muscle fibers were considered on the basis of the histochemical double staining for COX/SDH activities. 
This analysis revealed different profiles of mtDNA deletion abundance and distribution that likely result from 
different underlying mechanisms and timing of clonal expansion of the deleted molecules.
The patients with single mtDNA deletions had variable amounts of deleted molecules even in the COX pos-
itive fibers, indicating a stochastic distribution of the mtDNA deletion, which presumably occurred in the early 
stages of embryonic development or clonally expanded from a pre-existing pool in the oocyte. In contrast, the 
patients affected with DOA “plus” and carrying dominant OPA1 mutations leading to defective mitochondrial 
fusion had extremely low amounts of deleted mtDNA molecules in the COX positive fibers, comparable to con-
trols. This indicates that the fusion defect favored over lifespan the clonal expansion of pre-existing mtDNA dele-
tions, possibly those normally accumulated with ageing, but only in specific domains of the muscle fibers. This 
might be due to the fusion defect that limited the clonal expansion along the length of the fiber, keeping the COX 
negative domain restricted. Finally, the patients affected by SANDO syndrome, due to recessive POLG mutations 
leading to defective mtDNA replication, had increased amounts of deleted mtDNA molecules in the COX positive 
fibers, intermediate between controls/OPA1 patients and single deletion patients. This would suggest that mtDNA 
multiple deletions accumulate at accelerated rate somatically over the lifespan of patients, with increased rate of 
clonal expansion in specific domains of the muscle fibers that might expand in the length of the fiber over time.
Figure 4. Level of mtDNA deletions in longitudinal fibres obtained by ddPCR. The highest load of mtDNA 
deletions was detected in the COX negative fiber segments (blue dots) from the single deletion group. All 
measurements were performed in triplicates. Longitudinal fibers were analyzed from the following patients: 
OPA1 group (P1); POLG (P3); single deletion group (P5). The mean values for each group of fibers are presented 
with black horizontal lines.
Figure 5. MtDNA copy number density assessed by ddPCR. The groups represent pooled data of fibres from 
different patients; OPA1 group (P1 and P2); POLG group (P3 and P4); single deletion group (P5, P6 and P7); 
control group (C1, C2 and C3). All measurements were performed in triplicates. The mean values for each 
group are presented with black horizontal lines. Levels of significance: **P = 0.001–0.01; ***P < 0.001.
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Noticeably, we assessed mtDNA copy number, as a surrogate measure of activated mitochondrial biogene-
sis in the same single cells we used for assessing the loads of mtDNA deleted molecules. The results provided 
evidence that where the deletion load was highest, higher mtDNA copy number was also recognized. In other 
words, the COX negative fibers in single deletion cases and the RBFs in both single deletion and POLG had the 
highest mtDNA copy number, demonstrating the strongest attempt to compensate for OXPHOS deficiency by 
compensatory activation of mitochondrial biogenesis. Thus, these results provide compelling evidence that if 
the mtDNA deletion crosses a certain threshold to trigger compensatory mitochondrial biogenesis and mtDNA 
replication, the deleted molecules take advantage for their own numeric expansion28. The mtDNA copy number 
is tightly regulated and dependent on the balanced processes of mitochondrial biogenesis and clearance by mito-
phagy, which maintain the mitochondrial network mass through highly regulated cycles of fusion and fission of 
organelles16. Recent studies on Caernorhabditis elegans (C. elegans) strains carrying a single mtDNA deletion pro-
vided evidence that the deleted molecules highjack the activation of the mitochondrial unfolded protein response 
(mtUPR) to clonally expand, implicating either reduced mitophagy29 or activated mitochondrial biogenesis and 
organelle dynamics30. Interestingly, Gitschlang et al. investigated the issue of a possible replicative advantage of 
the deleted mtDNA molecules, due to their shorter length31,32 failing to find any evidence that this actually occurs 
in C. elegans29. Similarly, a study addressing the same issue in human skeletal muscle also found no appreciable 
differences in the rate of clonal expansion between mtDNA deletions of different sizes33.
The mechanisms of reduced mitophagy or activated mitochondrial biogenesis and dynamics are not mutually 
exclusive, and they have all been implicated in both physiological and pathological states in skeletal muscle, the 
tissue used in the current study. The investigation of murine animal models with impaired fusion, as obtained by 
conditional deletions of both Mitofusins Mfn1 and Mfn2, has previously shown that mitochondrial dynamics is 
crucial for mtDNA maintenance34. More recently, the rate of fusion in single muscle fibers has been linked to specific 
and discrete mitochondrial domains correlated with oxidative capacity35. Thus, the local impairment of OXPHOS 
may unbalance mitochondrial dynamics and the relative rates of mitophagy and mitochondrial biogenesis, trigger-
ing a complex series of tightly connected events that may ultimately lead to the clonal expansion of deleted mtDNA 
molecules, which is remarkably restricted to these mitochondrial domains. However, in a recent study utilizing a 
Drosophila Melanogaster model, the loads of a heteroplasmic mtDNA deletion were reduced and the pathological 
phenotype ameliorated by stimulation of autophagy, activation of the PINK1/Parkin pathway or decreasing the lev-
els of Mitofusins, all strategies aimed at limiting mitochondrial fragments to fuse again with the network and, thus, 
promoting their mitophagic elimination36. The complex role that mitochondrial dynamics plays has also been mod-
eled mathematically showing that a higher rate of fusion-fission can provide faster clearance of mutant mtDNA, only 
when transiently existing mutant-rich mitochondria are efficiently prevented from re-fusing with other mitochon-
dria and selectively removed37. Otherwise, faster fusion-fission accelerates the accumulation of mutant mtDNA38–40.
The different profiles of distribution and loads of deleted mtDNA molecules found by our study in the differ-
ent categories of muscle fibers, in particular in the COX positive fibers, possibly reflect these purported mecha-
nisms currently proposed for clonal expansion of deleted mtDNA.
In conclusion, our results shed new insight on the complex interrelated mechanisms underlying the clonal 
expansion of mtDNA deletions, crucially indicating different profiles dependent on the specific genetic defect 
and, possibly, on the time points of the original mutational event.
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